L.F. Will et Cie SA
L.F. Will et Cie reported total assets of €1.21m at the end of the 2025 financial year (annual accounts filed with the NBB on 06 Jul 2026).
The score of L.F. Will et Cie shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -44 % Total assets -54 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
L.F. Will et Cie's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 06 Jul 2026
- Year ended 31 Dec 2024filed on 27 Jun 2025
- Year ended 31 Dec 2023filed on 16 Jul 2024
- Year ended 31 Dec 2022filed on 25 Jul 2023
- Year ended 31 Dec 2021filed on 25 Jul 2022
L.F. Will et Cie's financial analysis
- Solvency86.8%sector median: 43.9%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of L.F. Will et Cie
L.F. Will et Cie's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0402.188.427
- VAT number
- BE0402188427
- Peppol
- Registered · 0208:0402188427 · as of 10 Nov 2026
- Legal form
- SA
- Incorporated
- 01 Apr 1969
- Registered office
- 1301 Wavre
- Latest accounts
- 2025 · filed on 06 Jul 2026
- Activity
- Wholesale of pharmaceutical and medical goods (NACE 46460)
L.F. Will et Cie (SA) has been based in Wavre since 1969, active in: wholesale of pharmaceutical and medical goods. For 2025, it reports a net profit of 135 € and equity of €1.05m; its revenue is not published. Its solvency stands at 86.8%, above the median of its sector (43.9%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to L.F. Will et Cie
Companies in the same business, of comparable size and area, outside its group.
- SPGL Ltd Wholesale of pharmaceutical and medical goods · balance sheet €1.01m
- Bausch & Lomb Pharma Wholesale of pharmaceutical and medical goods Wavre · balance sheet €9.17m
- Pharmaceutical industries Advice Wholesale of pharmaceutical and medical goods Rixensart · balance sheet 27,340 €
- UPSA Belgium Wholesale of pharmaceutical and medical goods Etterbeek · balance sheet €104.2m
- Wolf-Safco Wholesale of pharmaceutical and medical goods Overijse · balance sheet €1.25m
- Uniphar Wholesale of pharmaceutical and medical goods Brussels · balance sheet 476,976 €
- Almirall Wholesale of pharmaceutical and medical goods Zaventem · balance sheet €7.75m
- ixX pharma Wholesale of pharmaceutical and medical goods Antwerp · balance sheet €11.3m
Frequently asked questions about L.F. Will et Cie
What is the revenue of L.F. Will et Cie?
L.F. Will et Cie files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of L.F. Will et Cie?
In Belgium, the VAT number is the company number prefixed with BE: BE0402188427 for L.F. Will et Cie, if the company is VAT-registered. Its company number (CBE) is 0402.188.427.
Where is the registered office of L.F. Will et Cie?
According to the CBE register, the registered office of L.F. Will et Cie is in 1301 Wavre.
What is the equity of L.F. Will et Cie?
At the close of the 2025 financial year, the equity of L.F. Will et Cie amounts to 1,051,719 €, a solvency of 86.8% of total assets.
Who manages L.F. Will et Cie?
The register lists 4 active mandates at L.F. Will et Cie. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of L.F. Will et Cie
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →